Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer

Area of Science:

• Biotechnology
• Genetics
• Oncology

Background:

• CRISPR-associated nuclease 9 (Cas9) technology has emerged as a powerful tool in cancer research.
• Lung cancer studies have benefited from CRISPR/Cas9 for target gene identification, animal model construction, and drug resistance gene discovery.

Purpose of the Study:

• To review the current applications of CRISPR/Cas9 technology in lung cancer treatment.
• To provide a basis for future research and clinical implementation of CRISPR/Cas9 in lung cancer therapy.

Main Methods:

• Literature review of CRISPR/Cas9 applications in lung cancer research and treatment.
• Analysis of CRISPR/Cas9's role in gene therapy, molecular targeted drugs, and inhibitors for lung cancer.

Main Results:

• CRISPR/Cas9 facilitates identification of lung cancer target genes and drug resistance mechanisms.
• The technology aids in constructing relevant animal tumor models for lung cancer research.
• CRISPR/Cas9 shows potential in gene therapy for lung cancer, including targeted drug development.

Conclusions:

• CRISPR/Cas9 technology is a rapidly advancing field with significant promise for lung cancer treatment.
• Continued in-depth and systematic research is crucial for the successful clinical translation of CRISPR/Cas9 in lung cancer therapy.